![]() |
市场调查报告书
商品编码
1918014
剂量计市场 - 2026-2031年预测Dosimeter Market - Forecast from 2026 to 2031 |
||||||
预计剂量计市场将从 2025 年的 30.04 亿美元成长到 2031 年的 43.09 亿美元,复合年增长率为 6.2%。
剂量计——用于测量累积或即时电离辐射暴露量的装置——已成为医疗、核能、工业射线照相和国防应用领域不可或缺的安全工具。现代产品系列涵盖了从被动式积分技术(光释光剂量计、热释光剂量计、胶片)到具有直接读数、警报功能和无线遥测功能的主动式电子个人剂量计(EPD)等多种类型。目前,领先的系统在1微西弗至10西弗的范围内可实现±10%的精度,而将法定记录功能与即时反馈相结合的混合型光释光/电子个人剂量计正日益普及。
医疗辐射防护领域仍是规模最大且成长最快的领域。 CT、介入萤光和影像导航放射治疗在全球范围内的广泛应用,显着增加了放射科医生、心臟科医生、肿瘤科医生和技术人员的职业辐射计量。监管剂量限值(五年平均每年20毫希沃特,单年50毫希沃特,适用于大多数司法管辖区)和ALARA原则要求在A类工作人员阈值以上的医疗机构中实施个人剂量监测。同时,欧盟指令2013/59/Euratom、医疗机构联合委员会(JCAHO)标准以及类似框架下的病患剂量追踪要求,正在推动医疗机构广泛采用区域监测和诊断参考水准(DRL)监测解决方案。
核能是第二大支柱。中国、印度和韩国的在运作中核电厂,以及中东欧新兴的核能发电厂项目,持续推进建设,从而对符合IEC 61526和ANSI N13.27标准的、性能可靠且灵敏度高的环境辐射检测器(EPD)产生了持续的需求。欧洲和北美地区的退役和废弃物管理活动也进一步推动了对具备污染反应能力和中子灵敏度的设备的长期需求。
亚太地区正崛起为强劲的成长引擎。中国承诺在2050年新建150多座核子反应炉,印度计画扩建22座反应堆,韩国正在兴建的APR-1400反应器,这些计画的产能扩张规模总和远远超过其他任何地区。同时,对先进医疗影像设备(特别是直线加速器和PET/CT扫描仪)的投资,正在形成区域协同效应。政府针对国内放射治疗和核子医学扫描术诊断设备製造生产连结奖励计画,进一步刺激了当地对符合标准的剂量测定係统的需求。
技术演进围绕着四个性能指标:
竞争环境有利于那些将硬体与认证剂量测定服务相结合的製造商(例如 Landauer、Mirion、Thermo Fisher、Fuji Electric 和 Chiyoda Technol)。纯硬体製造商由于中国製造商提供低成本被动式 OSL 阅读器而面临利润率压力,而精密主动式 EPD 的利润率则受到严格的核能认证标准(例如 10CFR35、IEC 60846-1 和 ANSI N42.20)的保护。
监管协调工作正在推进,实施速度也正在加快。国际原子能总署安全标准RS-G-1.1/1.3和国际放射性核种测量委员会/国际放射防护委员会建议的修订提案持续收紧职业暴露限值,并扩大强制监测范围。各国计画(如中国国家国防科技工业局、印度美国核能管理委员会、韩国核能安委员会)正日益与西方标准接轨,在全部区域形成统一的需求模式。
供应限制仍然较小,但主要集中在高纯度Al₂O₃:C和BeO OSL晶体以及中子级⁶LiF检测器,这些领域的全球认证产能仅限于少数专业工厂。在建设高峰期,获得完全符合IEC 61526第三版认证的核能级EPD(环境性能声明)的前置作业时间可能长达12-18个月。
对于辐射安全和设施管理人员而言,鑑于主动式系统能够减轻管理负担、即时预防辐射暴露并消除剂量计丢失事件,总体拥有成本模型如今通常足以证明其合理性。将个人、区域和患者剂量测定功能整合到单一供应商软体平台上的方案将带来最大的效率提升。
总体而言,剂量计在结构上占据有利地位,这得益于全球两大辐射暴露增长最快的领域(先进医学影像和新建核能发电厂)中强制性的监管要求、清晰的技术蓝图(该路线图正在扩大剂量计与传统胶片/热释光剂量计的性能差距)以及高认证门槛对现有企业的保护。将经认证的剂量测定服务与下一代无线/混合硬体和云端分析相结合的公司,预计将在这个受监管主导的安全领域保持两位数的成长和强劲的利润率。
它是用来做什么的?
产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及影响、新产品开发、竞争影响
Dosimeter Market, at a 6.2% CAGR, is projected to increase from USD 3.004 billion in 2025 to USD 4.309 billion in 2031.
Dosimeters-devices designed to measure cumulative or real-time exposure to ionizing radiation-have become indispensable safety tools across medical, nuclear energy, industrial radiography, and defense applications. Modern portfolios span passive integrating technologies (OSL, TLD, film) and active electronic personal dosimeters (EPDs) with direct-reading, alarming, and wireless telemetry capabilities. Leading systems now achieve +-10 % accuracy across 1 µSv-10 Sv ranges, with hybrid OSL/EPD units gaining traction for their combination of legal record-keeping and instant feedback.
Medical radiation protection remains the largest and fastest-growing segment. The global proliferation of CT, interventional fluoroscopy, and image-guided radiotherapy has dramatically increased occupational doses for radiologists, cardiologists, oncologists, and technologists. Regulatory dose limits (20 mSv/yr averaged over 5 years, 50 mSv single year in most jurisdictions) and ALARA principles drive mandatory personal monitoring in any facility exceeding Class A worker thresholds. Simultaneously, patient-dose tracking requirements under EU 2013/59/Euratom, U.S. Joint Commission standards, and similar frameworks are expanding institutional adoption of area and diagnostic reference level (DRL) monitoring solutions.
Nuclear energy represents the second major pillar. Operational fleets in China, India, South Korea, and emerging programs in the Middle East and Eastern Europe continue aggressive construction schedules, creating sustained demand for rugged, high-range EPDs certified to IEC 61526 and ANSI N13.27 standards. Decommissioning and waste-management activities in Europe and North America further amplify long-term requirements for contamination-capable and neutron-sensitive devices.
Asia-Pacific has emerged as the clear growth engine. China's commitment to 150+ new reactors by mid-century, India's 22-unit expansion pipeline, and South Korea's continued APR-1400 build-out collectively dwarf capacity additions elsewhere. Parallel investment in advanced medical imaging-particularly linear accelerators and PET/CT installations-creates a compounding regional effect. Government production-linked incentives for domestic radiotherapy and nuclear-imaging equipment manufacturing further accelerate local demand for compliant dosimetry systems.
Technology evolution centers on four performance vectors:
Competitive dynamics favor manufacturers that bundle hardware with accredited dosimetry services (Landauer, Mirion, Thermo Fisher, Fuji Electric, Chiyoda Technol). Pure hardware players face margin pressure from Chinese entrants offering low-cost passive OSL readers, while premium active EPD margins remain protected by stringent nuclear certification barriers (10CFR35, IEC 60846-1, ANSI N42.20).
Regulatory harmonization is accelerating adoption. IAEA Safety Standards RS-G-1.1/1.3 and forthcoming revisions to ICRU/ICRP recommendations continue to tighten occupational limits and expand mandatory monitoring categories. National programs-China's State Administration of Science, Technology and Industry for National Defense (SASTIND), India's Atomic Energy Regulatory Board (AERB), and Korea's Nuclear Safety and Security Commission (NSSC)-are aligning ever closer with Western benchmarks, creating uniform regional demand profiles.
Supply constraints remain modest but center on high-purity Al2O3:C and BeO OSL crystals, plus neutron-grade 6LiF detectors, where qualified global capacity is limited to a handful of specialized facilities. Lead times for nuclear-grade EPDs with full IEC 61526 Ed.3 certification can extend 12-18 months during construction peaks.
For radiation safety officers and facility managers, total-cost-of-ownership models now routinely justify premium active systems when factoring reduced administrative burden, real-time exposure prevention, and elimination of lost-badge events. Programs that integrate personal, area, and patient dosimetry under single-vendor software platforms capture the largest efficiency gains.
Overall, dosimeters occupy a structurally advantaged position: non-discretionary regulatory requirement in the world's two fastest-growing radiation-exposure sectors (advanced medical imaging and new-build nuclear), clear technology roadmaps that widen performance gaps versus legacy film/TLD, and high certification barriers that protect incumbents. Companies combining accredited dosimetry services with next-generation wireless/hybrid hardware and cloud analytics are positioned for sustained double-digit growth and resilient margins in this essential, regulation-driven safety category.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation: